{
  "trx_id": "0eb0ef2b4e642980a186be94d66662411f0958a8",
  "block": 77504641,
  "trx_in_block": 3,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-23T10:34:48",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "biochar",
      "author": "stephen.morrison",
      "permlink": "digging-into-the-growing-potential-of-the-biochar-market-benefits-challenges-and-sustainability",
      "title": "Digging Into the Growing Potential of the Biochar Market: Benefits, Challenges, and Sustainability",
      "body": "Biochar is a type of charcoal produced through the process of pyrolysis, which involves heating biomass (such as wood, agricultural waste, or other organic materials) in a low-oxygen environment. This process results in a stable carbon-rich material that can be used for various purposes, including soil enhancement, carbon sequestration, and energy production.\n\nThe global biochar market size is estimated to be valued at US$ 7.9 million in 2023 and to grow at a rate of 14.1% during the forecast period to reach a valuation of US$ 26.5 million by the end of 2033.\n\nKey factors that were driving the biochar market up to 2021 included:\n\n• Soil Amendment and Agriculture: Biochar is known for its ability to improve soil fertility, water retention, and nutrient availability. It can enhance plant growth and reduce the need for synthetic fertilizers. As sustainable agriculture practices gained attention, the demand for biochar in farming and gardening increased.\n• Carbon Sequestration: Biochar has the potential to sequester carbon in the soil for hundreds to thousands of years, thus helping to mitigate climate change by locking carbon dioxide from the atmosphere into a stable form.\n• Waste Management: Biochar production can utilize agricultural and forestry waste materials that would otherwise contribute to greenhouse gas emissions or be discarded. This aspect resonated with waste reduction and circular economy goals.\n• Renewable Energy: The process of pyrolysis that produces biochar also yields bio-oil and syngas, which can be used as sources of renewable energy.\n• Research and Development: Research into biochar applications, production techniques, and its effects on different soil types was ongoing, contributing to a deeper understanding of its potential benefits.\n\nHowever, as of 2021, the biochar market was still in a relatively early stage of development. \n\nChallenges included:\n• Market Awareness: Many farmers and industries were still unfamiliar with biochar and its potential benefits, leading to a lack of demand in some regions.\n• Cost and Scale: Producing biochar through pyrolysis can be energy-intensive, and the economies of scale were not always favorable for widespread adoption.\n• Regulation and Standards: The biochar industry faced challenges in establishing consistent quality standards and regulations.\n• Research Gaps: While there was promising research, some gaps existed in understanding the long-term effects of biochar on soil health, the environment, and crop productivity.\n\nGiven that there might have been developments since 2021, I recommend looking for more recent sources to get the most up-to-date information on the current state of the biochar market, including its growth, trends, challenges, and opportunities.\n\nTop Companies in Biochar Industry\nArSta Eco, Biochar Industries, Biochar Supreme, Carbon Gold, Karr Group, Phoenix Energy, Sunriver Biochar, Swiss Biochar GmbH, The Biochar Company LLC, Vega Biofuel.\n\nRead More @ https://www.factmr.com/report/3781/biochar-market",
      "json_metadata": "{\"tags\":[\"biochar\",\"agriculture\",\"chemical\",\"industry\"],\"links\":[\"https://www.factmr.com/report/3781/biochar-market\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "81083a651e8a62c1288b14d91f7e0a32045b4dca",
  "block": 77099417,
  "trx_in_block": 7,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:28:09",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "danieli98",
      "permlink": "esp-eng-una-especie-de-mariposa-gigante-a-kind-of-giant-butterfly",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "c3c08f4bbee21fcc07e6094301f292ed35fe0653",
  "block": 77099416,
  "trx_in_block": 4,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:28:06",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "afkar86",
      "permlink": "butterfly",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "f6c268dc689dd8717d609a9bc4fcd1af40f3af6b",
  "block": 77099415,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:28:03",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "danieli98",
      "permlink": "esp-eng-gusanos-blancos-en-los-arboles-white-worms-in-the-trees",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "695b07b5e1a6fd2f5810106876221a199aa450dc",
  "block": 77099414,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:28:00",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "merlyned",
      "permlink": "esp-eng-una-tara-en-mi-jardin-a-tare-in-my-garden",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "5738c7b23dad53f5c71d2d2c2f020e82760c0d79",
  "block": 77099413,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:57",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "merlyned",
      "permlink": "esp-eng-mis-adorables-mascotas-my-lovely-pets",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "3de5f4db44a6f5756baf1bd866ca9ab7057c3f0b",
  "block": 77099412,
  "trx_in_block": 2,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:54",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "soroka74",
      "permlink": "dva-kota-iz-miassa-rossiya-v-mezhdunarodnyi-koshkin-den",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "fdbcac097520cb82a5344bcebfb535a0399f94ff",
  "block": 77099411,
  "trx_in_block": 0,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:51",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "albanna",
      "permlink": "tame-eagle-in-a-decorative-cage",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "21ec2fa030ff06bebb9885a304eaaa92ca6f3018",
  "block": 77099409,
  "trx_in_block": 27,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:45",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "vavanellope",
      "permlink": "daily-hot-3-cute-animals-on-steemit-8-8-2023",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "84784f5afab17c376e2e429a048f77d49629fb10",
  "block": 77099407,
  "trx_in_block": 9,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:39",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "albanna",
      "permlink": "monyet-di-dalam-sangkar-hias-yang-jinak",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "ff23cd4d70b731719dafeec81c335b3a9a9ff42e",
  "block": 77099406,
  "trx_in_block": 0,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:36",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "voternisty",
      "permlink": "kelinci-anggora",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "c03855e96cd8c5b0623d42eb6e0edc9c7729244e",
  "block": 77099403,
  "trx_in_block": 3,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:27:27",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "stephen.morrison",
      "permlink": "animal-vaccines-market-size-to-reach-ususd-29-billion-by-2032",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "81d728c465db008755371da3d97133fe0bcce825",
  "block": 77099329,
  "trx_in_block": 2,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-08-09T07:23:45",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "animal",
      "author": "stephen.morrison",
      "permlink": "animal-vaccines-market-size-to-reach-ususd-29-billion-by-2032",
      "title": "Animal Vaccines Market Size to Reach US$ 29 Billion by 2032",
      "body": "The global animal vaccines market size is estimated at billion in 2021, is anticipated to rise at a CAGR of 9.2% from 2022 to 2032.\n\nSales of animal vaccinations are increasing as illness outbreaks in cattle and canine problems both rise. Additionally, government spending on R&D in various nations is having a beneficial impact on the demand for animal vaccines.\n\nRead More @ https://www.factmr.com/report/animal-vaccines-market\n\nKey Driving Forces Accelerating the Market Growth\n\nZoonotic diseases are infectious diseases that can be transmitted between animals and humans. The rising incidence of zoonotic diseases, such as rabies, avian influenza, and Lyme disease, has created a need for effective animal vaccines to prevent the spread of these diseases to humans.\n\nThere is a growing awareness among pet owners, livestock farmers, and veterinarians about the importance of animal health and preventive measures. This increased focus on animal health has led to a higher demand for vaccines to protect animals from various diseases.\nThe demand for protein-rich food products, such as meat, milk, and eggs, is increasing due to the growing global population and changing dietary preferences. To meet this demand, livestock farmers are adopting preventive measures, including vaccination, to protect their animals from diseases that can affect their productivity and health.\n\nGovernment bodies in North America have implemented regulations and initiatives to control and prevent the spread of animal diseases. These regulations often require the vaccination of animals to ensure public health and the safety of the food supply. The enforcement of such regulations has contributed to the growth of the animal vaccines market.\n\nMoreover, North America is expected to hold more than 23% of the market share for animal vaccines.\n\nDownload a Sample of this Report –\nhttps://www.factmr.com/connectus/sample?flag=S&rep_id=7123\n\nVital indicators shaping the Future of the Industry\n\nThe occurrence of disease outbreaks and epidemics in animals can have a significant impact on the animal vaccines market. The emergence of new or highly virulent diseases can drive the demand for vaccines and accelerate market growth. Monitoring and responding to disease outbreaks will continue to be a crucial indicator for the market's future.\nAdvances in technology, such as new vaccine delivery systems, adjuvants, and production techniques, can revolutionize the animal vaccines market. Innovative technologies that improve vaccine efficacy, safety, and ease of administration can shape the future of the market by driving adoption and expanding the range of available vaccines.\n\nThe regulatory landscape and government policies play a crucial role in shaping the animal vaccines market. Changes in regulations, such as requirements for mandatory vaccinations or modifications in vaccine approval processes, can significantly impact the market. Monitoring regulatory developments and adapting to changing requirements will be vital for market players.\n\nContinued investments in research and development (R&D) activities focused on animal vaccines will drive the future of the market. R&D efforts aimed at developing new vaccines, improving existing ones, and exploring advanced technologies will contribute to market growth. Increased R&D funding and collaborations between industry players and research institutions will be key indicators to watch.\n\nChallenges hindering the market growth\n\nThe stringent regulatory requirements for the approval and registration of animal vaccines can pose significant challenges for manufacturers. The complex and lengthy regulatory processes, including clinical trials and safety assessments, can delay product launches and increase costs, inhibiting market growth.\n\nDeveloping and commercializing animal vaccines involves substantial investment in research, development, and clinical trials. The high costs associated with vaccine development, including manufacturing and quality control, can be a deterrent for smaller companies and hinder the entry of new players into the market.\nStrategies for manufacturers/suppliers to scale in the market\n\nInvesting in R&D is crucial to develop innovative vaccines that address emerging diseases, improve efficacy, and enhance safety. Allocating resources to R&D activities enables manufacturers to stay ahead of competitors, offer differentiated products, and meet evolving market needs.\n\nExpanding the product portfolio by introducing a wide range of vaccines for different animal species and diseases can help manufacturers/suppliers capture a larger market share. This strategy allows them to cater to diverse customer demands and strengthens their position as a comprehensive solution provider.\n\nForming strategic partnerships and collaborations with other industry players, research institutions, or government agencies can provide access to complementary expertise, resources, and distribution networks. Collaborative efforts can facilitate product development, enhance market reach, and open doors to new customer segments.\n\nFor instance, In January 2022, USA FDA approved Solensia TM to control the pain of osteoarthritis in cats and help improve their mobility, comfort, and overall well-being.\n\nIn August 2020, Merck & Co., Inc. completed the acquisition of IdentiGEN. The company is focusing on studying DNA of animals for livestock. Through this acquisition, Merck intends to provide complete transparency to food processors, producers and retailers, regarding animal traceability solutions to ensure that good quality food is available to consumers\n\nIn January 2022, Zoetis Inc. announced that the U.S Food and Drug Administration has approved SolensiaTM (frunevetmab injection) to control the pain of osteoarthritis in cats, helping improve their mobility, comfort and overall well-being. The injection works by directly targeting the Nerve Growth Factor (NGF), a key OA pain driver.\n\nKey Companies Profiled\n\nMerck & Co. Inc.\nZoetis Inc.\nBoehringer Ingelheim International GmbH\nVirbac\nBiogenesis Bago\nIndian Immunologicals Ltd.\nElanco Animal Health Incorporated\nCEVA Animal Health (Pty) Ltd.\nPhibro Animal Health Corporation\nNEOGEN Corporation\n\nWhat differences can the animal vaccines report make on the revenue impacts and strategies of businesses?\n\nFact.MR strives to provide comprehensive assessments of opportunities in various regions and technology segments. The study also offers an uncluttered data-driven insights into the growth avenues of the animal vaccines and all its segments. \n\nSome of the ways the study can make a discernible impact are by offering evidence-based perspectives on:\n\nAttractiveness quotient of emerging product/technology types in various products in the animal vaccines\nMicro-economics factors that may hamper the prospects of some of the key segments\nRecent spate of research and development (R&D) funding on key animal vacciness\nNew business models paving way for disruptions in demand dynamic of key segments\nRegional markets that will be future engine of growth and the industry trends that will support these markets\nChallenges overcoming which may offer industry players competitive edge",
      "json_metadata": "{\"tags\":[\"animal\",\"vaccines\",\"market\"],\"links\":[\"https://www.factmr.com/report/animal-vaccines-market\",\"https://www.factmr.com/connectus/sample?flag=S&rep_id=7123\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "91cabd30f99b5307ccb3b6a6a25fc89adf57ac98",
  "block": 76730744,
  "trx_in_block": 7,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-07-27T11:05:15",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "notify",
      "json": "[\"setLastRead\",{\"date\":\"2023-07-27T11:03:00\"}]"
    }
  ]
}

{
  "trx_id": "73f56b44584fe6ce9763bd902f526a893d9d7507",
  "block": 76730656,
  "trx_in_block": 0,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-07-27T11:00:51",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "behavioural",
      "author": "stephen.morrison",
      "permlink": "behavioural-health-treatment-market-europe-is-expected-to-retain-its-leadership-role",
      "title": "Behavioural Health Treatment Market: Europe is Expected to Retain its Leadership Role",
      "body": "The global behavioral health treatment market is expected to witness significant growth in the future, primarily due to the increasing adoption of telepsychiatry practices. Additionally, a surge in mental health issues arising from factors like stress, peer pressure, and socioeconomic challenges is expected to further drive the demand for behavioral health services.\n\nThe industry of behavioral health services is experiencing remarkable growth, primarily attributed to the growing awareness and availability of treatment options for various health issues. With the expansion of healthcare facilities and the integration of advanced technologies, the sector is making significant strides in addressing behavioral health challenges. As a result, the industry is expanding rapidly and enhancing the overall quality of care offered to patients.\n\nThe growth of the behavioral health treatment market has been substantial in recent years. There has been a notable increase in awareness and recognition of mental health issues, leading to a greater demand for effective treatment options. \nSeveral factors contribute to this growth:\n\nReduced Stigma: There has been a gradual decline in the stigma surrounding mental health problems, encouraging more individuals to seek help and treatment for their behavioral health issues.\n\nIncreased Awareness: Governments, organizations, and advocacy groups have been actively working to raise awareness about mental health, leading to a better understanding of its significance and the importance of seeking treatment.\n\nTechnological Advancements: The integration of advanced technologies, such as telepsychiatry and mental health apps, has made behavioral health treatment more accessible and convenient for people.\n\nHealthcare Reforms: Many countries have implemented healthcare reforms that prioritize mental health services, making it easier for individuals to access treatment and support.\n\nChanging Lifestyles: Modern lifestyles, with increased stress, peer pressure, and societal challenges, have contributed to a rise in mental health issues, leading to a greater demand for behavioral health treatment.\n\nResearch and Development: Continuous research and development efforts in the field of behavioral health have resulted in innovative treatment approaches and therapies.\n\nIntegrated Care: The integration of behavioral health services with primary care and other medical specialties has improved the overall coordination and effectiveness of treatment.\n\nWorkplace Initiatives: Many companies and organizations have started offering mental health support programs for their employees, recognizing the impact of mental well-being on productivity and overall health.\n\nOverall, the growth of behavioral health treatment can be attributed to a combination of factors that emphasize the importance of mental health and the need for effective and accessible treatment options. As societies continue to prioritize mental health, the behavioral health treatment sector is likely to see further expansion and advancements in the future.\n\nRead More @ https://www.factmr.com/report/4370/behavioural-health-treatment-market",
      "json_metadata": "{\"tags\":[\"behavioural\",\"health\",\"treatment\",\"market\"],\"links\":[\"https://www.factmr.com/report/4370/behavioural-health-treatment-market\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "acd22e96235e13ab0d7dcc8af40c776e38aee5a5",
  "block": 76477188,
  "trx_in_block": 4,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-07-18T14:16:06",
  "op": [
    "transfer",
    {
      "from": "alexmove.witness",
      "to": "stephen.morrison",
      "amount": "0.001 STEEM",
      "memo": "Hi, stephen.morrison! If you like contests, then I invite you to take part in a series of contests \"Workplace\" from SelfDevelopment Club. Total prize fund: 375 STEEM. Details in the SelfDevelopment Club community. Have a good day, stephen.morrison! Good luck! 20230718"
    }
  ]
}

{
  "trx_id": "fee4b44b329a76112b700ca82cbc09309338464a",
  "block": 76476272,
  "trx_in_block": 10,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-07-18T13:30:03",
  "op": [
    "transfer",
    {
      "from": "alexmove.witness",
      "to": "stephen.morrison",
      "amount": "0.001 STEEM",
      "memo": "Please support me @alexmove.witness as witness on site https://steemitwallet.com/~witnesses. I send daily Witness vote STEEM reward and developing a learning project SelfDevelopment Club. Your vote is very important to me, stephen.morrison! Good luck! 20230718"
    }
  ]
}

{
  "trx_id": "9e791e7c9845334813bae4c86665a47fa707a185",
  "block": 76476008,
  "trx_in_block": 6,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-07-18T13:16:48",
  "op": [
    "transfer",
    {
      "from": "beemengine",
      "to": "stephen.morrison",
      "amount": "0.001 STEEM",
      "memo": "⚡️Supercharge your content's reach and engagement with Beemengine! Boost your visibility, attract a larger audience, and skyrocket your upvotes 🚀 . Join now at just 1 HIVE/STEEM per month for 24/7 auto voting, a thriving 🌐 community of 1.5k+ interactions, up to 100K boosted posts, tens of dedicated curators, and effortless passive earnings 💰 . Don't miss out - subscribe today at beemengine.com or reply 'subscribe' for a one-month subscription for just 1 HIVE/STEEM"
    }
  ]
}

{
  "trx_id": "f3e192455e94bf188231539ae88307b35e0f4aeb",
  "block": 76475988,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2023-07-18T13:15:48",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "audiology",
      "author": "stephen.morrison",
      "permlink": "how-audiology-devices-market-would-grow-significantly-in-next-five-years",
      "title": "How Audiology Devices Market Would Grow Significantly in Next Five Years",
      "body": "Audiological Devices Market Outlook (2022-2032)\n\nBasic hearing aids occasionally perform poorly in crowded environments. Hearing assistive technology (HAT) employs frequency modulation, infrared, and induction loop systems to lessen the impact of background noise, distance, and reverberation. The HAT devices can be used without hearing aids.\n\nThe growing demand for inexpensive goods, technological advancements like wireless devices, and the growing acceptance of such technologically advanced goods are additional factors influencing product demand for audiology devices. The prevalence of illnesses like Meniere's disease, which affect hearing, is also anticipated to rise, which is anticipated to fuel market expansion.\n\nThe Audiological Devices market size reached a valuation of US$ 10.27 Billion by 2021, and is likely to register a Y-o-Y growth rate of 4.0% in 2022, closing at US$ 10.81 Billion. Furthermore, across the 2022-2032 period of assessment.\n\nRead More @ https://www.factmr.com/report/4444/audiological-devices-market\n\nInnovation in developed countries' technologies and products\n\nDuring the anticipated time frame, a favourable regulatory environment is anticipated to promote market expansion for audiology devices. In order to make over-the-counter hearing aids easily accessible to consumers through retail locations without the need for audiologist intervention, the FDA and the European Commission have developed favourable regulations.\n\nKey Takeaway\n\n•\tHearing aids accounted for a market share of more than 64% of total revenue for audiology devices.\n•\tThe BAHA/BAHS segment is anticipated to grow the market for audiology devices.\n•\tWith a revenue share of more than 74%, retail establishments dominated the market for audiology equipment.\n•\tOver the forecast years, the e-commerce segment is expected to grow at the fastest rate.\n•\tThe digital technology sector accounted for more than 92.6% of the total revenue on the global market for audiology devices.\n•\tThe adult market, which also received the largest revenue share, dominated the sector.\n•\tNorth America dominated the global market for audiology devices, accounting for more than 41.55% of all sales.\n•\tThe fastest CAGR is predicted for the Asia Pacific region.\n•\t19% of the total revenue came from the Indian market.\n•\tDuring the forecast period, the European market for audiology devices is anticipated to expand at a CAGR of 4.6%.\n\nRecent Development\n\nAcquisition\n\nA subsidiary of Demant A/S, Oticon Medical, was purchased by Cochlear Ltd. in April 2021. The deal, which cost USD 170 million, will help Cochlear Ltd. grow its clientele by adding 75,000 Oticon Medical hearing aid users.\n\nProduct Launch\n\nIn October 2021, the health technology company Audibel unveiled the Arc-AI hearing aid. It is programmed to automatically adjust hearing volume and comes in a variety of designs, including behind-the-ear and fully in-canal styles.\n\nIn January 2019, Lively introduced an online audiology platform that provides all customers with hearing aids, exams, and round-the-clock online support. All platform users can communicate with an audiologist via video conference and purchase hearing aids without needing to visit a clinic or retail location.\n\nIn August 2019, Oticon unveiled two new digital hearing aids: the Oticon Xceed power hearing aid and the Oticon Xceed Play paediatric hearing aid. It is run on the Velox S platform and uses Oticon BrainHearing technology. The Opensound Optimizer and Opensound Navigator.\n\nCompetitive Landscape\n\nA few key players are active on both a global and regional scale in the competitive environment for audiology devices on a worldwide scale, which is moderately fragmented. Major players are forming strategic alliances to enlarge their individual portfolios and gain a foothold on the global market.\n\nAMBCO, Benson Medical Instruments, Cochlear, GN Store Nord, MED-EL, MedRX, Medtronic, Nurotron Biotechnology, Sivantos, WIDEX, Sonova, Starkey Hearing Technologies, and William Demant are a few of the companies active in the market.\n\nProminent Audiological Devices Service Players\n\nWilliam Demant Holding A/S\nGN Store Nord A/S\nSonova\nWIDEX A/S\nSivantos Pte. Ltd.",
      "json_metadata": "{\"tags\":[\"audiology\",\"devices\",\"market\"],\"links\":[\"https://www.factmr.com/report/4444/audiological-devices-market\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "6c20b2fe248a91b5da3609b175d9a23cc3a720a1",
  "block": 55438657,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2021-07-13T06:56:09",
  "op": [
    "transfer",
    {
      "from": "executive-board",
      "to": "stephen.morrison",
      "amount": "0.001 STEEM",
      "memo": "❗ Hello stephen.morrison, great that you are using the STEEM blockchain. The Executive Board is publishing insider infos at https://discord.gg/KyBbmhh on how you will be earning the most coins. It's easy, just follow the instructions. THE 1000X BOOSTER KEY is already waiting for you over there too. 😉 Warm regards, The Executive Board."
    }
  ]
}

{
  "trx_id": "f076e23aec472bc124b0ec9e0bbc29eb1ecb3776",
  "block": 55438623,
  "trx_in_block": 0,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2021-07-13T06:54:27",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "surgicalrobotics",
      "author": "stephen.morrison",
      "permlink": "in-the-crowded-surgical-robotics-market-there-s-room-for-innovation-covid-19-impact-analysis",
      "title": "In the Crowded Surgical Robotics Market, There’s Room for Innovation: COVID-19 Impact Analysis",
      "body": "The global surgical robotics market was valued at $56,294.9 million in 2017, and is projected to reach $98,737.0 million by 2024, growing at a CAGR of 8.5% from 2017 to 2024. The orthopedic surgery dominated the market in terms of revenue and accounted for about one-fifth share of the global market in 2017.\n\nRead More @ https://www.alliedmarketresearch.com/surgical-robotics-market\n\nSurgical robotic system is a technologically advanced surgical solution, used mainly during complicated surgical procedures. The surgical robotic system includes surgeons console, surgical arms and monitoring systems & software. The surgical robotic system market is gaining prominence in the recent years owing to rapid technological advancements, increasing investments in research and development and its extensive application in critical surgeries such as cardiac, orthopedic and neurosurgery. Further, wide scope of applications in different surgeries, increasing demands for advanced medical facilities and rising incidence of diseases such as cancer and musculoskeletal ailments & injuries, majorly supplement the growth of surgical robotics market. On the contrary, high costs of surgical robotic procedures, lack of awareness and inadequate presence of expertise professionals are major factors impeding the market growth.\n\nDownload Sample Report at: https://www.alliedmarketresearch.com/request-sample/852\n\nThe global surgical robotics market is segmented into component, surgery type and region. Based on component, the market is segmented into systems, accessories, and services. The surgical robotics market based on surgery type is segmented into gynecology surgery, urology surgery, neurosurgery, orthopedic surgery, general surgery and others. Regionally the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.\n\nIn terms of revenue, the accessories in component segment accounted for the highest market share in 2017, owing to rising adoption of surgical robotic systems across Tier-1 hospitals, recurrent sales of accessories for these systems and demand for highly efficient replaceable components. Surgical robotic systems services would emerge as the lucrative segment since it is mandatory for every surgical robotic systems buyer to maintain the system's performance. The services segment would exhibit the fastest growth rate, registering a CAGR of 15.7% during the forecast period.\n\nBased on surgery type, the neurosurgery segment accounted for about one-sixth share of the total market in terms of value as well as volume and is expected to grow at a CAGR of 8.6% and 6.5% respectively during the forecast period. As robotic systems were primarily used for neurosurgeries and later widen its application. The need for precision during neurosurgery has led to an increase in adoption for surgical robotics.\n\nFor Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/852\n\nKEY FINDINGS OF THE STUDY\n\n- The gynecology surgery accounted for about one-sixth share of the global market in terms of revenue as well as volume in 2017.\n- The surgical systems segment by component accounted for one-third share of the global market in 2017 and is expected to grow at a CAGR of 11.3% during the forecast period.\n- The U.S. dominated the North American surgical robotics market in 2017 by surgery type and is projected to grow at a CAGR of 7.0% during the forecast period.\n- Spain is expected to be the fastest growing country in the European surgical robotics market by surgery type with a CAGR of 12.3% during 2018-2024.\n- India is expected to be the fastest growing country in the Asia-Pacific surgical robotics market by surgery type during the forecast period.\n\nNorth America dominated the surgical robotics market. The market growth in North America is primarily a reflection of product innovations and launches resulting from technological advancements. The companies mostly adopted product launch, acquisition, and expansion as their key strategies to keep pace with the changing demands of consumers and strengthen their market position. The key players operating in the global surgical robotics market are Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Auris Surgical Robotics Inc. (Hansen Medical Inc.), Intuitive Surgical, Inc., KUKA AG, Stryker Corporation (MAKO Surgical Corp.), Mazor Robotics, Renishaw plc., Medtronic, THINK Surgical, Inc., and Zimmer Biomet Holdings Inc. Other players operating in the value chain are Transenterix, Verb Surgical, Titan Medical, Microbot Medical, Accuray and Medrobotics.\n\nContact Info:\nName: Allied Market Research\nEmail: Send Email\nOrganization: Allied Market Research\nAddress: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States\nPhone: +1-800-792-5285\nWebsite: https://www.alliedmarketresearch.com/",
      "json_metadata": "{\"tags\":[\"surgicalrobotics\",\"robotics\",\"surgical\"],\"links\":[\"https://www.alliedmarketresearch.com/surgical-robotics-market\",\"https://www.alliedmarketresearch.com/request-sample/852\",\"https://www.alliedmarketresearch.com/purchase-enquiry/852\",\"https://www.alliedmarketresearch.com/\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "0295ea36fe36ef0f9deacf4d38671e170366738a",
  "block": 43201100,
  "trx_in_block": 30,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2020-05-08T16:08:18",
  "op": [
    "delegate_vesting_shares",
    {
      "delegator": "steem",
      "delegatee": "stephen.morrison",
      "vesting_shares": "1953.311140 VESTS"
    }
  ]
}

{
  "trx_id": "da1fbdce3dc0e2a893696913d1498a96bc9c0eef",
  "block": 42183239,
  "trx_in_block": 3,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2020-04-02T10:09:12",
  "op": [
    "delegate_vesting_shares",
    {
      "delegator": "steem",
      "delegatee": "stephen.morrison",
      "vesting_shares": "9785.900703 VESTS"
    }
  ]
}

{
  "trx_id": "69c5689cb4a0973a686ab3c57005efc96e269753",
  "block": 40356750,
  "trx_in_block": 22,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2020-01-29T16:21:33",
  "op": [
    "comment",
    {
      "parent_author": "stephen.morrison",
      "parent_permlink": "how-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "author": "steemitboard",
      "permlink": "steemitboard-notify-stephenmorrison-20200129t162134000z",
      "title": "",
      "body": "Congratulations @stephen.morrison! You received a personal award!\n\n<table><tr><td>https://steemitimages.com/70x70/http://steemitboard.com/@stephen.morrison/birthday1.png</td><td>Happy Birthday! - You are on the Steem blockchain for 1 year!</td></tr></table>\n\n<sub>_You can view [your badges on your Steem Board](https://steemitboard.com/@stephen.morrison) and compare to others on the [Steem Ranking](https://steemitboard.com/ranking/index.php?name=stephen.morrison)_</sub>\n\n\n###### [Vote for @Steemitboard as a witness](https://v2.steemconnect.com/sign/account-witness-vote?witness=steemitboard&approve=1) to get one more award and increased upvotes!",
      "json_metadata": "{\"image\":[\"https://steemitboard.com/img/notify.png\"]}"
    }
  ]
}

{
  "trx_id": "0a66f3b5a0dde1de530d9544202848dedc70b8b6",
  "block": 34673652,
  "trx_in_block": 10,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-15T04:11:36",
  "op": [
    "vote",
    {
      "voter": "spaminator",
      "author": "stephen.morrison",
      "permlink": "how-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "weight": -5
    }
  ]
}

{
  "trx_id": "12abce26aea53e313945323601538ed833bf7326",
  "block": 34571004,
  "trx_in_block": 9,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:33:54",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"restmode\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "f6d04a532358233b0d66e22bc02bd8bc30c3259a",
  "block": 34570973,
  "trx_in_block": 18,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:32:21",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"deathcross\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "2e5af49771af8298a685090e8799693702571c6e",
  "block": 34570971,
  "trx_in_block": 21,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:32:15",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"anomadsoul\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "26c31c2d542441b3363f1dfaa37d9f64783030ca",
  "block": 34570955,
  "trx_in_block": 0,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:31:27",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"news-daily\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "546cc43cc80b68982312a7e0ddecd3e898eed73a",
  "block": 34570949,
  "trx_in_block": 9,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:31:09",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"devkant79\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "f95878aaae7bf2e6fba98feeff23fbb4adf517b7",
  "block": 34570948,
  "trx_in_block": 5,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:31:06",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"shopinbit\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "1120988dc89f489f62dc97e48588ea7d297e678c",
  "block": 34570947,
  "trx_in_block": 14,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:31:03",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"zaku\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "906b4475ea2af9fbd1e1749c6f7f582191aa581c",
  "block": 34570946,
  "trx_in_block": 9,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:31:00",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"hatu\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "1b059978bd21cf402697f5ab04ccd00aa0fddb86",
  "block": 34570945,
  "trx_in_block": 9,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:30:57",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"majes.tytyty\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "408bb26c54411e1b7e937753fe442ca136cbad23",
  "block": 34570901,
  "trx_in_block": 4,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:28:45",
  "op": [
    "vote",
    {
      "voter": "stephen.morrison",
      "author": "ytrphoto",
      "permlink": "3cqkr1",
      "weight": 10000
    }
  ]
}

{
  "trx_id": "cbe9b07068257d6ba650eb4c7ce9d4b7634062ae",
  "block": 34570898,
  "trx_in_block": 9,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:28:36",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"lagiaguara\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "34344e9cdf5cbfa136a0306b43d8dd953b7246f4",
  "block": 34570897,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-11T14:28:33",
  "op": [
    "custom_json",
    {
      "required_auths": [],
      "required_posting_auths": [
        "stephen.morrison"
      ],
      "id": "follow",
      "json": "[\"follow\",{\"follower\":\"stephen.morrison\",\"following\":\"swiftcash\",\"what\":[\"blog\"]}]"
    }
  ]
}

{
  "trx_id": "f16ae4e529c58138224937cd7edf8909cef8c124",
  "block": 34486659,
  "trx_in_block": 13,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-08T16:12:48",
  "op": [
    "vote",
    {
      "voter": "mack-bot",
      "author": "stephen.morrison",
      "permlink": "how-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "weight": -50
    }
  ]
}

{
  "trx_id": "f8b7e9474b9685170d2912e6d9f4887ee67063ff",
  "block": 34486639,
  "trx_in_block": 27,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-08T16:11:48",
  "op": [
    "comment",
    {
      "parent_author": "stephen.morrison",
      "parent_permlink": "how-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "author": "cheetah",
      "permlink": "cheetah-re-stephen-morrisonhow-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "title": "",
      "body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttps://www.alliedmarketresearch.com/press-release/multiplex-assays-market.html",
      "json_metadata": ""
    }
  ]
}

{
  "trx_id": "a3f9d0b19b26dada7129e19f4012eb38e4361e89",
  "block": 34486638,
  "trx_in_block": 19,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-08T16:11:45",
  "op": [
    "vote",
    {
      "voter": "cheetah",
      "author": "stephen.morrison",
      "permlink": "how-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "weight": 8
    }
  ]
}

{
  "trx_id": "fdef66896ed508c7989fc440b4d698ebd996ff6c",
  "block": 34486635,
  "trx_in_block": 8,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-07-08T16:11:36",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "multiplex",
      "author": "stephen.morrison",
      "permlink": "how-multiplex-assays-market-would-grow-significantly-in-next-five-years",
      "title": "How Multiplex Assays Market Would Grow Significantly in Next Five Years",
      "body": "The global Multiplex Assays Market was valued at $3,470 million in 2015 and is expected to garner $5,720 million by 2022, registering a CAGR of 7.4% during the forecast period 2016-2022. The protein-based multiplex assays segment held over the two-thirds share of the total market in 2015. Protein-based multiplex assays are expected to dominate the global multiplex assays market during the forecast period, owing to their rise in adoption to analyze unknown proteins and their functions simultaneously and precisely.\n\nRequest For PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1921\n\nMultiplex assays are techniques that analyze multiple analytes at the same time. Multiplex assays extract more data from a sample in less time as compared to single-plex assays. The key factors that drive the growth of the market include increase in research & development activities for the detection of biomarkers for various diseases & treatment options of the diseases; rise in adoption of personalized medicine for increasing safety & efficacy of therapies; benefits, such as lower operational cost & reduced labor; and technological advancements. However, a shortage of skilled labor and high capital investment are expected to restrain the market growth during the forecast period.\n\nThe multiplex assays market in this report is studied on the basis of type, product, technology, application, end user, and geography. Based on type, it is divided into nucleic acid-based multiplex assays, protein-based multiplex assays, and other multiplex assays. Protein-based multiplex assays held the highest share over two-thirds in 2015, owing to high usage of multiplex assays for the differentiation of proteins on the basis of their properties in different fields, such as diagnostic clinics, research & development, and others.\n\nBy-product the market is classified into multiplex assay consumables, multiplex assays instruments & accessories, and multiplex assay software & services. The multiplex assays reagents & consumable market held the highest share of three-fourths in 2015 and is expected to lead the market during the analysis period. Pharmaceuticals &biotechnological companies in end users held the highest market share of multiplex assays market in 2015, and are expected to show the highest growth rate during the analysis period, owing to the extensive use of multiplex assays in the R&D by pharmaceutical and biotechnology companies.\n\nGeographically, the global multiplex assays market is analyzed by four regions, namely, North America, Europe, Asia-Pacific, and LAMEA. North America was the highest revenue contributor with approximately half of the share in 2015 and is attributed to the ample amount of expenditure in healthcare, research & development, well-established healthcare system, and higher demand for technically advanced devices for research work. However, Asia-Pacific is anticipated to grow with the highest CAGR during the analysis period, owing to the rise in healthcare expenditure, increase in per capita income & improved healthcare infrastructure.\n\nGet More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/1921\n\nKey Findings of Multiplex Assays Market\n\n• The multiplex assays reagents & consumable market accounted for the highest market share for the product segment in 2015 and is also estimated to grow at the highest CAGR of 7.7% in the analysis period.\n• By application, research and development held the highest market share and expected to lead the market during the analysis period.\n• The U.S. was the highest shareholder in the North American multiplex assays market, accounting for a six-sevenths share in 2015.\n• China is expected to show the highest growth rate during the analysis period in the Asia-Pacific multiplex assays market.\n\nThe key players profiled in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd.\n\n\nTable Of Content\n\t\nChapter: 1 INTRODUCTION\n1.1. REPORT DESCRIPTION\n1.2. KEY BENEFITS\n1.3. KEY MARKET SEGMENT\n1.4. RESEARCH METHODOLOGY\n1.4.1. Secondary research\n1.4.2. Primary research\n1.4.3. Analyst tools and models\n \nChapter: 2 EXECUTIVE SUMMARY\n2.1. KEY FINDINGS OF THE STUDY\n2.2. CXO PERSPECTIVE\n\nChapter: 3 MARKET OVERVIEW\n3.1. MARKET DEFINITION AND SCOPE\n3.2. KEY FINDINGS\n3.2.1. Top investment pockets\n3.2.2. Top winning strategies\n3.3. PORTERS FIVE FORCES ANALYSIS\n3.3.1. Bargaining power of buyers\n3.3.2. Bargaining power of suppliers\n3.3.3. Threat of substitutes\n3.3.4. Threat of new entrants\n3.3.5. Competitive rivalry\n3.4. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, 2015\n3.5. MARKET DYNAMICS\n3.5.1. Drivers\n3.5.2. Restraints\n3.5.3. Opportunities\n\nAccess Full Summery @ https://www.alliedmarketresearch.com/multiplex-assays-market",
      "json_metadata": "{\"tags\":[\"multiplex\",\"assays\",\"market\"],\"links\":[\"https://www.alliedmarketresearch.com/request-sample/1921\",\"https://www.alliedmarketresearch.com/purchase-enquiry/1921\",\"https://www.alliedmarketresearch.com/multiplex-assays-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "faf33b58b1ac3bc26b308a46878770212f89ea1a",
  "block": 33865694,
  "trx_in_block": 20,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-06-17T01:54:21",
  "op": [
    "vote",
    {
      "voter": "spaminator",
      "author": "stephen.morrison",
      "permlink": "tavi-market-growth-analysis-and-key-business-strategies-by-leading-industry-players-or-forecast-2018-2025",
      "weight": -5
    }
  ]
}

{
  "trx_id": "71cad93695402982c415e79b70655a7f647f9f0a",
  "block": 33843531,
  "trx_in_block": 19,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-06-16T07:25:00",
  "op": [
    "vote",
    {
      "voter": "mack-bot",
      "author": "stephen.morrison",
      "permlink": "tavi-market-growth-analysis-and-key-business-strategies-by-leading-industry-players-or-forecast-2018-2025",
      "weight": -50
    }
  ]
}

{
  "trx_id": "0a3149b550197fb9e295377d38f1f71a1ba5654d",
  "block": 33678727,
  "trx_in_block": 49,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-06-10T13:54:42",
  "op": [
    "comment",
    {
      "parent_author": "stephen.morrison",
      "parent_permlink": "tavi-market-growth-analysis-and-key-business-strategies-by-leading-industry-players-or-forecast-2018-2025",
      "author": "cheetah",
      "permlink": "cheetah-re-stephen-morrisontavi-market-growth-analysis-and-key-business-strategies-by-leading-industry-players-or-forecast-2018-2025",
      "title": "",
      "body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttps://www.alliedmarketresearch.com/press-release/tavi-market.html",
      "json_metadata": ""
    }
  ]
}

{
  "trx_id": "6b76613f15d319f0cd0fb3488e8a328f8c3a33d2",
  "block": 33678726,
  "trx_in_block": 35,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-06-10T13:54:39",
  "op": [
    "vote",
    {
      "voter": "cheetah",
      "author": "stephen.morrison",
      "permlink": "tavi-market-growth-analysis-and-key-business-strategies-by-leading-industry-players-or-forecast-2018-2025",
      "weight": 8
    }
  ]
}

{
  "trx_id": "7e0cc56504fcebc1f8f612bbf3e17fb9421ea9e7",
  "block": 33678720,
  "trx_in_block": 19,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-06-10T13:54:21",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "lifescience",
      "author": "stephen.morrison",
      "permlink": "tavi-market-growth-analysis-and-key-business-strategies-by-leading-industry-players-or-forecast-2018-2025",
      "title": "TAVI Market Growth Analysis & Key Business Strategies By Leading Industry Players | Forecast, 2018-2025",
      "body": "The TAVI market revenue was valued at $2,761 million in 2017 and is expected to reach $8,138 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The volume market was valued at 107,011 units in 2017 and is expected to reach 337,778 units by 2025, growing at a CAGR of 14.8% from 2018 to 2025.\n\nDownload Sample Report @ https://www.alliedmarketresearch.com/request-sample/1675\n\nTranscatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. These high-risk patients refer to the patient population that are inoperable and cannot undergo surgical aortic valve replacement (SAVR) procedure. Older population (above 75 years of age) falls under the high-risk category, as the open-heart procedure is too risky for them. TAVR involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise due to the increase in prevalence of aortic stenosis.\n\nThe TAVI market is in its growth phase, and is mainly driven by rise in prevalence of aortic stenosis and increase in geriatric population. In addition, increase in adoption rate of transcatheter aortic implantation along with new device approvals and improvement of healthcare infrastructure in developing countries are other factors that fuel the market growth. However, high cost of transcatheter aortic valve and its implantation procedures, along with lack of reimbursement and stringent approvals for these devices, hamper the growth of the TAVI market.\n\nThe report segments the TAVI market based on the approach used for implantation. Mainly, three types of approaches are used to implant the transcatheter aortic valve in patients-transfemoral, transapical, and transaortic implantation. Transfemoral implantation was the highest revenue-generating segment in the global market (in terms of value and volume) in 2017, as it does not require a chest incision. Furthermore, transaortic segment is projected to grow at the highest CAGR of 19.1% (in terms of value) and 20.1% (in terms of volume) by 2025, due to positive outcomes of several clinical trials.\n\nKey Findings of the Transcatheter Aortic Valve Implantation (TAVI) Market:\n\n• In 2017, transfemoral implantation generated the highest revenue, and is projected to grow at a CAGR of 13.2% (in terms of value) during the forecast period.\n• Both in terms of value and volume, the Europe TAVI market is expected to maintain its leading position during the forecast period.\n• Asia-Pacific is expected to be the fastest growing region, and is expected to grow with a CAGR of 18.6% (in terms of value) from 2018 to 2025.\n• Germany was the leading country whereas the UK is projected to be the fastest growing country in the Europe TAVI market.\n• India is the fastest growing country in the Asia-Pacific TAVI market and is expected to grow at a CAGR of 29.8% (in terms of revenue) from 2018 to 2025.\n\nEurope accounted for a major share in the global TAVI market (in terms of value and volume) in 2017, and is expected to maintain this trend. This is attributed to the rise in prevalence of severe aortic stenosis cases coupled with the increase in population of inoperable patients, and high adoption rate of advanced transcatheter aortic valves. However, Asia-Pacific is estimated to grow at a high CAGR (in terms of value and volume) throughout the analysis period, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of aortic stenosis and increase in awareness about TAVI procedures among physicians.\n\nFor More Details @ https://www.alliedmarketresearch.com/purchase-enquiry/1675\n\nKey players have adopted product approval as their key strategy to enhance their product offerings by expanding the usage of transcatheter aortic valves for new indications, such as intermediate risk aortic stenosis patients. The key players profiled in this report include Abbott Laboratories, Boston Scientific Corporation (Symetis SA), Bracco S.p.A. (HLT, Inc.), Edwards Lifesciences Corporation, JenaValve Technology, Inc., JC Medical, Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG, and Venus Medtech, Inc.\n\n\nTable Of Content\n\t\nCHAPTER 1: INTRODUCTION\n1.1. REPORT DESCRIPTION\n1.2. KEY BENEFITS FOR STAKEHOLDERS\n1.3. KEY MARKET SEGMENTS\n1.4. KEY PLAYERS\n1.5. RESEARCH METHODOLOGY\n1.5.1. Secondary research\n1.5.2. Primary research\n1.5.3. Analyst tools and models\n\nCHAPTER 2: EXECUTIVE SUMMARY\n2.1. KEY FINDINGS OF THE STUDY\n2.2. CXO PERSPECTIVE\n\nCHAPTER 3: MARKET OVERVIEW\n3.1. MARKET DEFINITION AND SCOPE\n3.2. KEY FINDINGS\n3.2.1. Top investment pockets\n3.2.2. Top winning strategies\n3.3. PORTER’S FIVE FORCES ANALYSIS\n3.3.1. Bargaining power of suppliers\n3.3.2. Bargaining power of buyers\n3.3.3. Threat of new entrants\n3.3.4. Intensity of rivalry\n3.3.5. Threat of substitutes\n3.4. MARKET SHARE ANALYSIS, 2017\n3.5. GOVERNMENT REGULATIONS\n3.5.1. U.S. FDA\n3.5.2. Europe CE Mark\n3.5.3. Ministry of Health, Labour and Welfare (MHLW)\n3.6. CLINICAL TRIALS\n3.7. MARKET DYNAMICS\n3.7.1. Drivers\n3.7.1.1. Rise in prevalence of aortic stenosis coupled with increase in geriatric population\n3.7.1.2. Increase in adoption rate for transcatheter aortic valve implantation procedure\n3.7.1.3. Increase in clinical evidence of safety and efficacy and new device approvals\n3.7.1.4. Increase in number of TAVR Centers\n3.7.2. Restraints\n3.7.2.1. High cost of the device and unfavorable reimbursement policies\n3.7.2.2. Stringent regulatory approval process\n3.7.3. Opportunities\n3.7.3.1. Use of TAVI systems for new indications\n3.7.3.2. Rise in healthcare expenditure of developing countries\n3.7.3.3. Increase in interest of local to global players in the TAVI market\n3.7.4. Impact Analyses....\n\nAccess Full Summery | https://www.alliedmarketresearch.com/tavi-market",
      "json_metadata": "{\"tags\":[\"lifescience\",\"healthcare\",\"tavi\",\"tavr\"],\"links\":[\"https://www.alliedmarketresearch.com/request-sample/1675\",\"https://www.alliedmarketresearch.com/purchase-enquiry/1675\",\"https://www.alliedmarketresearch.com/tavi-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "347f1b9183d8d03255a5d0f9a4082220a786e60a",
  "block": 32845176,
  "trx_in_block": 7,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-05-12T14:38:39",
  "op": [
    "vote",
    {
      "voter": "steemcleaners",
      "author": "stephen.morrison",
      "permlink": "cardiac-biomarkers-market-is-expected-to-reach-usd2-085-9-million",
      "weight": -2000
    }
  ]
}

{
  "trx_id": "89876e9352b85ce886176cbec622dcc508713600",
  "block": 32845174,
  "trx_in_block": 34,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-05-12T14:38:33",
  "op": [
    "comment",
    {
      "parent_author": "stephen.morrison",
      "parent_permlink": "cardiac-biomarkers-market-is-expected-to-reach-usd2-085-9-million",
      "author": "steemcleaners",
      "permlink": "re-stephenmorrison-cardiac-biomarkers-market-is-expected-to-reach-usd2-085-9-million-20190512t143834498z",
      "title": "",
      "body": "Added to @spaminator for spam.",
      "json_metadata": "{\"tags\":[\"cardiac\"],\"users\":[\"spaminator\"],\"app\":\"steemit/0.1\"}"
    }
  ]
}

{
  "trx_id": "865b7dbb19c97ed2e0329e463cd13c412cb5857b",
  "block": 32761950,
  "trx_in_block": 43,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-05-09T17:15:51",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "cardiac",
      "author": "stephen.morrison",
      "permlink": "cardiac-biomarkers-market-is-expected-to-reach-usd2-085-9-million",
      "title": "Cardiac Biomarkers Market is Expected to Reach $2,085.9 Million",
      "body": "Cardiac Biomarkers Market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the period 2015-2020. Cardiac Troponins (T, I) would continue to dominate the market throughout the forecast period due to high sensitivity and specificity.\n\nDownload PDF Sample: https://www.alliedmarketresearch.com/request-sample/309\n![Cardiac Biomarkers Market.jpg](https://cdn.steemitimages.com/DQmP54n88WRwHVkzUiUS3E8qgPAbzjW69VURhXEEJ4JAJma/Cardiac%20Biomarkers%20Market.jpg)\nCardiac biomarkers are protein-based traceable substances used as an indicator of biological state for diagnostic and prognostic purposes associated with cardiac conditions. Commercialization of highly advanced and accurate type of cardiac biomarkers has provided a novel platform for diagnosis of cardiac diseases. Continuous focus on pipeline research and developments from leading players and increased patient awareness across untapped regions such as India, China is largely driving the growth of cardiac biomarkers market. The growing application of cardiac biomarkers as point of care (POC) testing facilitate quick results in chronic conditions, thus drives the market growth. However, specificity and sensitivity related concerns of single measurement cardiac biomarkers, premium pricing and certain government regulations would hinder the market growth. Also, the overall market growth would bank on novel progress made in cardiac treatments using multi-assay biomarkers. The life saving benefits of these multi-assay biomarkers would foster the revenue generation process as well as market penetration of novel cardiac biomarkers in the future.\n\nKey findings of Cardiac Biomarkers Market:\n\n-Troponin segment is projected as a leading market segment throughout the forecast period\n-Revenue of myocardial infarction application segment is expected to grow almost threefold by 2020\n-Laboratory location of testing market segment still dominates the global market\n-Point of care location of testing segment is projected to grow at a CAGR of 22% during the forecast period\n-Countries like India and China holds prominent potential owing to higher count of undiagnosed cardiac patients\n\nThe principal strategy adopted by the leading players in the market is the product launch. The key companies profiled in the report are Abbott laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation, Beckman Coulter, Becton, Dickinson and Company, Thermo Fisher Scientific, BioMerieux, Bio-Rad Laboratories and Randox laboratories.\n\nPurchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/309",
      "json_metadata": "{\"tags\":[\"cardiac\",\"biomarkers\"],\"image\":[\"https://cdn.steemitimages.com/DQmP54n88WRwHVkzUiUS3E8qgPAbzjW69VURhXEEJ4JAJma/Cardiac%20Biomarkers%20Market.jpg\"],\"links\":[\"https://www.alliedmarketresearch.com/request-sample/309\",\"https://www.alliedmarketresearch.com/purchase-enquiry/309\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "4878d6ced3b4f2310e9f3e7ec06ab1ce92192563",
  "block": 32673663,
  "trx_in_block": 22,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-05-06T15:39:45",
  "op": [
    "comment",
    {
      "parent_author": "stephen.morrison",
      "parent_permlink": "the-u-s-accounted-for-highest-share-of-global-ivf-market-at-usd4-472-2-million-by-2022",
      "author": "cheetah",
      "permlink": "cheetah-re-stephen-morrisonthe-u-s-accounted-for-highest-share-of-global-ivf-market-at-usd4-472-2-million-by-2022",
      "title": "",
      "body": "Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:\nhttps://issuu.com/alliedanalytics1/docs/u.s_ivf_services_market",
      "json_metadata": ""
    }
  ]
}

{
  "trx_id": "ad80bd07df15b7de010e620297515e7a826a9891",
  "block": 32673662,
  "trx_in_block": 13,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-05-06T15:39:42",
  "op": [
    "vote",
    {
      "voter": "cheetah",
      "author": "stephen.morrison",
      "permlink": "the-u-s-accounted-for-highest-share-of-global-ivf-market-at-usd4-472-2-million-by-2022",
      "weight": 8
    }
  ]
}

{
  "trx_id": "25412e1e4f3d9d0fa68cfd50fb2c293bc4f2d204",
  "block": 32673656,
  "trx_in_block": 4,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-05-06T15:39:24",
  "op": [
    "comment",
    {
      "parent_author": "",
      "parent_permlink": "ivf",
      "author": "stephen.morrison",
      "permlink": "the-u-s-accounted-for-highest-share-of-global-ivf-market-at-usd4-472-2-million-by-2022",
      "title": "The U.S. Accounted for Highest Share of Global IVF Market at $4,472.2 Million by 2022",
      "body": "The U.S. IVF services market was valued at $2,213.1 million in 2015, and is estimated to reach $4,472.2 million by 2022, registering a CAGR of 10.6% from 2016 to 2022. Fresh IVF cycles (non-donor) segment held more than one-third share of the total market in 2015. Rise in incidence of late parenthood and decrease in total fertility rate drive the growth of the market. In addition, increase in popularity of IVF technique that helps one conceive propels market growth.\n\nDownload Report Sample: https://www.alliedmarketresearch.com/request-sample/3491\n\nIn vitro fertilization is a type of assisted reproductive technology, which involves the artificial fertilization of egg with sperm in laboratory settings and then resulting zygote is implanted into the uterus. According to the Society for Assisted Reproductive Technology (SART), in 2013 about 1.5% babies born in the U.S. were conceived through IVF procedures\n\nDelay in parenthood, increase in number of infertility cases due to age concern, and increase in trend of middle age pregnancies drive the market. In addition, rise in health awareness on fertility issues, adoption of advanced IVF procedures, and increase in consumption of alcohol and cigarettes leading to sedentary lifestyles further fuel the market growth. However, factor such as expensive IVF treatments and stringent government regulations restrain the market growth. The upsurge in demand for novel IVF technologies and rise in disposable incomes are expected to provide numerous opportunities for market growth during the forecast period.\n\nThe overall number of embryo transfers performed in U.S. stood at 180.4 thousand in 2015 and is expected to reach 353.7 thousand by 2022, registering a CAGR of 10.1% during the forecast period. The growth of the market is associated with modern lifestyle, increase in infertility rate among couples, availability of advanced technology, and skilled IVF technicians.\n\nThe fertility clinics segment is anticipated dominate the market during the forecast period in terms of volume and revenue. This is due to the reason that fertility clinics provide technologically advanced and wide range of fertility treatments under one roof for patients.\n\nGet More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/3491\n\nKey Findings of the U.S. IVF Services Market:\n\n• Based on cycle type, in 2015, fresh IVF cycle (non-donor) segment accounted for around half share of the total market, in terms of revenue and volume.\n• Based on end user, clinical research institutes segment is projected to be one of the fastest growing segment at a CAGR of 11.1% in terms of revenue.\n• Based on end user, in 2015, fertility clinics segment accounted for around three-fifths share of the total market in terms of volume.\n\nKey players in the U.S. IVF services market includes companies, hospitals, surgical centers, fertility centers, and clinical research institutes. These are Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.\n\n\nTABLES OF CONTENT\n\nChapter: 1 INTRODUCTION\n1.1. REPORT DESCRIPTION\n1.2. KEY MARKET BENEFITS\n1.3. KEY MARKET SEGMENTS\n1.4. RESEARCH METHODOLOGY\n1.4.1. Secondary research\n1.4.2. Primary research\n1.4.3. Analyst tools and models\n\nChapter: 2 EXECUTIVE SUMMARY\n2.1. KEY FINDING OF THE STUDY\n\nChapter: 3 MARKET OVERVIEW\n3.1. MARKET DEFINITION AND SCOPE\n3.2. OVERVIEW\n3.3. MARKET SIZE AND FORECAST\n3.3.1. Number of infertility clinics, 2015\n3.4. REGULATORY ISSUES, LEGISLATIONS, AND AUTHORITIES\n3.5. INSURANCE REIMBURSEMENT SCENARIO\n3.6. KEY IMPACTING FACTORS\n3.6.1. Drivers\n3.6.1.1. Increasing popularity of IVF in the U.S.\n3.6.1.2. Increased rate of infertility and practices of embryo banking cycles\n3.6.1.3. Delayed pregnancy\n3.6.1.4. Technological advancements in IVF treatment\n3.6.2. Restraints\n3.6.2.1. High cost of IVF treatments in the U.S.\n3.6.2.2. Restrictions on three-parent IVF treatments\n3.6.2.3. Scattered Reimbursements\n\nAccess Full Summery @ https://www.alliedmarketresearch.com/US-IVF-services-market",
      "json_metadata": "{\"tags\":[\"ivf\",\"fertilization\"],\"links\":[\"https://www.alliedmarketresearch.com/request-sample/3491\",\"https://www.alliedmarketresearch.com/purchase-enquiry/3491\",\"https://www.alliedmarketresearch.com/US-IVF-services-market\"],\"app\":\"steemit/0.1\",\"format\":\"markdown\"}"
    }
  ]
}

{
  "trx_id": "aff712f19d47ff354edca0032be2296e259fb5b8",
  "block": 32501815,
  "trx_in_block": 21,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-04-30T16:20:45",
  "op": [
    "delegate_vesting_shares",
    {
      "delegator": "steem",
      "delegatee": "stephen.morrison",
      "vesting_shares": "9981.642611 VESTS"
    }
  ]
}

{
  "trx_id": "6069d9f5d4a1b58d3af11a40570b2bd6ad2092f1",
  "block": 29946807,
  "trx_in_block": 26,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-01-31T20:24:33",
  "op": [
    "delegate_vesting_shares",
    {
      "delegator": "steem",
      "delegatee": "stephen.morrison",
      "vesting_shares": "30098.578710 VESTS"
    }
  ]
}

{
  "trx_id": "554d00b942364aa041fb61cebbd2694bb619864d",
  "block": 29882332,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-01-29T14:39:09",
  "op": [
    "delegate_vesting_shares",
    {
      "delegator": "steem",
      "delegatee": "stephen.morrison",
      "vesting_shares": "30300.000000 VESTS"
    }
  ]
}

{
  "trx_id": "554d00b942364aa041fb61cebbd2694bb619864d",
  "block": 29882332,
  "trx_in_block": 1,
  "op_in_trx": 0,
  "virtual_op": 0,
  "timestamp": "2019-01-29T14:39:09",
  "op": [
    "create_claimed_account",
    {
      "creator": "steem",
      "new_account_name": "stephen.morrison",
      "owner": {
        "weight_threshold": 1,
        "account_auths": [],
        "key_auths": [
          [
            "STM6e8QVbUAkf1M3Hrb6g5PfKQgW1KjVEDGNsCUUggx5ng4vrvkoU",
            1
          ]
        ]
      },
      "active": {
        "weight_threshold": 1,
        "account_auths": [],
        "key_auths": [
          [
            "STM4w9QcgXipKqpmZb5NcKFsvcfRiQg5wBLufW5Pcrf5MBorYfjzb",
            1
          ]
        ]
      },
      "posting": {
        "weight_threshold": 1,
        "account_auths": [],
        "key_auths": [
          [
            "STM8FGktju79YaRUUS91LECbkpFuUxkNRoJMP4BjzSnn9tu64y4mM",
            1
          ]
        ]
      },
      "memo_key": "STM8muHkue7eL9rSnB9z2qbYtC5ULq1CgANLPYJvru7WkVKTFFqCm",
      "json_metadata": "{}",
      "extensions": []
    }
  ]
}